nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—schizophrenia	0.964	1	CbGaD
Anagrelide—PDE3A—blood plasma—schizophrenia	0.00256	0.264	CbGeAlD
Anagrelide—CYP1A2—urine—schizophrenia	0.00217	0.224	CbGeAlD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS1—schizophrenia	0.00134	0.051	CbGpPWpGaD
Anagrelide—CYP1A2—blood plasma—schizophrenia	0.00113	0.117	CbGeAlD
Anagrelide—PDE3A—blood—schizophrenia	0.000939	0.0968	CbGeAlD
Anagrelide—PDE3A—G alpha (s) signalling events—TAAR6—schizophrenia	0.00083	0.0315	CbGpPWpGaD
Anagrelide—PDE3A—endocrine gland—schizophrenia	0.000814	0.0839	CbGeAlD
Anagrelide—PDE3A—cerebellum—schizophrenia	0.000717	0.0739	CbGeAlD
Anagrelide—PDE3A—G alpha (s) signalling events—HTR6—schizophrenia	0.000693	0.0263	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—ATP2A2—schizophrenia	0.000655	0.0248	CbGpPWpGaD
Anagrelide—PDE3A—brain—schizophrenia	0.000582	0.06	CbGeAlD
Anagrelide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—schizophrenia	0.000578	0.0219	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—NOS1—schizophrenia	0.000523	0.0199	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—PDE4B—schizophrenia	0.000507	0.0192	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—ADORA2A—schizophrenia	0.000484	0.0183	CbGpPWpGaD
Anagrelide—CYP1A2—Methylation—COMT—schizophrenia	0.000475	0.018	CbGpPWpGaD
Anagrelide—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.00043	0.0163	CbGpPWpGaD
Anagrelide—CYP1A2—blood—schizophrenia	0.000416	0.0428	CbGeAlD
Anagrelide—PDE3A—G alpha (s) signalling events—NPS—schizophrenia	0.000413	0.0157	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—PLA2G4A—schizophrenia	0.000407	0.0154	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—DRD1—schizophrenia	0.000405	0.0154	CbGpPWpGaD
Anagrelide—CYP1A2—endocrine gland—schizophrenia	0.00036	0.0372	CbGeAlD
Anagrelide—CYP1A2—Xenobiotics—CYP2D6—schizophrenia	0.00036	0.0137	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—HTR7—schizophrenia	0.000355	0.0135	CbGpPWpGaD
Anagrelide—CYP1A2—Tamoxifen metabolism—CYP2D6—schizophrenia	0.000346	0.0131	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—CLOCK—schizophrenia	0.000343	0.013	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—DGKI—schizophrenia	0.000337	0.0128	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—TPH1—schizophrenia	0.000305	0.0116	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—COMT—schizophrenia	0.000297	0.0113	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000277	0.0105	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen Receptor Pathway—ESR1—schizophrenia	0.000277	0.0105	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000273	0.0104	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—GSTM1—schizophrenia	0.000271	0.0103	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—CYP2D6—schizophrenia	0.000267	0.0101	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000224	0.00851	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—MAG—schizophrenia	0.000217	0.00824	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DGKI—schizophrenia	0.000213	0.00808	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—MAOA—schizophrenia	0.000201	0.00763	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IL3RA—schizophrenia	0.000194	0.00734	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DGKI—schizophrenia	0.000193	0.00734	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GCLM—schizophrenia	0.000182	0.00689	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PPP1R1B—schizophrenia	0.000177	0.00671	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—NDST3—schizophrenia	0.000171	0.00651	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GRM2—schizophrenia	0.00017	0.00646	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—TAAR6—schizophrenia	0.00017	0.00646	CbGpPWpGaD
Anagrelide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.000168	0.00638	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—FZD3—schizophrenia	0.000164	0.00624	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NGEF—schizophrenia	0.000158	0.00598	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—TAAR6—schizophrenia	0.000155	0.00587	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PPP3CC—schizophrenia	0.000155	0.00587	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GRM2—schizophrenia	0.000155	0.00587	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NTS—schizophrenia	0.000154	0.00584	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—APOE—schizophrenia	0.000152	0.00578	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—FGA—schizophrenia	0.000151	0.00571	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.000149	0.00567	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000147	0.00559	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ATP2A2—schizophrenia	0.000147	0.00557	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—RGS4—schizophrenia	0.000145	0.00549	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GRM3—schizophrenia	0.000145	0.00549	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NGEF—schizophrenia	0.000143	0.00543	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR6—schizophrenia	0.000142	0.00539	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NTS—schizophrenia	0.00014	0.00531	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—GSK3B—schizophrenia	0.000132	0.00501	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GRM3—schizophrenia	0.000131	0.00499	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—RGS4—schizophrenia	0.000131	0.00499	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR6—schizophrenia	0.000129	0.0049	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CHRM1—schizophrenia	0.000126	0.00476	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL3RA—schizophrenia	0.000122	0.00464	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000121	0.0046	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.00012	0.00455	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP26B1—schizophrenia	0.000119	0.00452	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP26B1—schizophrenia	0.000118	0.00446	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS1—schizophrenia	0.000117	0.00445	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GRM5—schizophrenia	0.000117	0.00443	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DGKI—schizophrenia	0.000114	0.00433	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CHRM1—schizophrenia	0.000114	0.00432	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL3RA—schizophrenia	0.000111	0.00421	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCK—schizophrenia	0.000107	0.00405	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GCLM—schizophrenia	0.000106	0.00403	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GRM5—schizophrenia	0.000106	0.00402	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PPP1R1B—schizophrenia	0.000104	0.00396	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PDE4B—schizophrenia	0.000104	0.00395	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CCKAR—schizophrenia	0.000102	0.00388	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—schizophrenia	0.000101	0.00382	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—ADORA2A—schizophrenia	9.92e-05	0.00376	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FZD3—schizophrenia	9.71e-05	0.00369	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCK—schizophrenia	9.69e-05	0.00368	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PDE4B—schizophrenia	9.44e-05	0.00358	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CCKAR—schizophrenia	9.29e-05	0.00353	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NPY—schizophrenia	9.27e-05	0.00352	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FES—schizophrenia	9.13e-05	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PPP3CC—schizophrenia	9.13e-05	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TAAR6—schizophrenia	9.13e-05	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GRM2—schizophrenia	9.13e-05	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PLA2G4A—schizophrenia	9.12e-05	0.00346	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	9.11e-05	0.00346	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—ADORA2A—schizophrenia	9.01e-05	0.00342	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR1B—schizophrenia	8.94e-05	0.00339	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—OXT—schizophrenia	8.94e-05	0.00339	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR1A—schizophrenia	8.61e-05	0.00327	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—YWHAZ—schizophrenia	8.57e-05	0.00325	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—NPS—schizophrenia	8.48e-05	0.00322	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NGEF—schizophrenia	8.45e-05	0.00321	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NPY—schizophrenia	8.42e-05	0.00319	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—COMT—schizophrenia	8.33e-05	0.00316	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD1—schizophrenia	8.31e-05	0.00315	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR2C—schizophrenia	8.31e-05	0.00315	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GSTP1—schizophrenia	8.3e-05	0.00315	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NTS—schizophrenia	8.26e-05	0.00313	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR1B—schizophrenia	8.12e-05	0.00308	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—OXT—schizophrenia	8.12e-05	0.00308	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD3—schizophrenia	8.05e-05	0.00306	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR1A—schizophrenia	7.82e-05	0.00297	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD4—schizophrenia	7.82e-05	0.00297	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RGS4—schizophrenia	7.77e-05	0.00295	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GRM3—schizophrenia	7.77e-05	0.00295	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—RTN4—schizophrenia	7.77e-05	0.00295	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—NPS—schizophrenia	7.7e-05	0.00292	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GSTM1—schizophrenia	7.62e-05	0.00289	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR6—schizophrenia	7.62e-05	0.00289	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR2C—schizophrenia	7.55e-05	0.00286	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD1—schizophrenia	7.55e-05	0.00286	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CNR1—schizophrenia	7.46e-05	0.00283	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—APOA1—schizophrenia	7.42e-05	0.00281	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MAG—schizophrenia	7.36e-05	0.00279	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD3—schizophrenia	7.31e-05	0.00277	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD2—schizophrenia	7.28e-05	0.00276	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR7—schizophrenia	7.28e-05	0.00276	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD4—schizophrenia	7.1e-05	0.00269	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CNR1—schizophrenia	6.78e-05	0.00257	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CHRM1—schizophrenia	6.73e-05	0.00255	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—schizophrenia	6.72e-05	0.00255	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR7—schizophrenia	6.61e-05	0.00251	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD2—schizophrenia	6.61e-05	0.00251	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL3RA—schizophrenia	6.56e-05	0.00249	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP2D6—schizophrenia	6.43e-05	0.00244	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NRG3—schizophrenia	6.4e-05	0.00243	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TLE1—schizophrenia	6.4e-05	0.00243	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP2D6—schizophrenia	6.35e-05	0.00241	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GFAP—schizophrenia	6.33e-05	0.0024	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	6.33e-05	0.0024	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	6.33e-05	0.0024	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GRM5—schizophrenia	6.26e-05	0.00238	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TLE3—schizophrenia	6.06e-05	0.0023	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—schizophrenia	6.01e-05	0.00228	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—schizophrenia	6.01e-05	0.00228	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCK—schizophrenia	5.72e-05	0.00217	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PDE4B—schizophrenia	5.58e-05	0.00212	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CCKAR—schizophrenia	5.49e-05	0.00208	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ADORA2A—schizophrenia	5.32e-05	0.00202	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PLA2G4A—schizophrenia	5.23e-05	0.00199	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—FGA—schizophrenia	5.1e-05	0.00194	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR2A—schizophrenia	5.1e-05	0.00194	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	5.06e-05	0.00192	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NPY—schizophrenia	4.97e-05	0.00189	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ATP2A2—schizophrenia	4.97e-05	0.00189	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NOTCH4—schizophrenia	4.97e-05	0.00189	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—COMT—schizophrenia	4.88e-05	0.00185	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—schizophrenia	4.87e-05	0.00185	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—schizophrenia	4.87e-05	0.00185	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GSTP1—schizophrenia	4.85e-05	0.00184	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—MAOA—schizophrenia	4.84e-05	0.00184	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—COMT—schizophrenia	4.81e-05	0.00182	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—OXT—schizophrenia	4.8e-05	0.00182	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR1B—schizophrenia	4.8e-05	0.00182	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—GSTP1—schizophrenia	4.79e-05	0.00182	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR2A—schizophrenia	4.63e-05	0.00176	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR1A—schizophrenia	4.62e-05	0.00175	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NPS—schizophrenia	4.55e-05	0.00173	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD1—schizophrenia	4.46e-05	0.00169	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR2C—schizophrenia	4.46e-05	0.00169	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GSTM1—schizophrenia	4.46e-05	0.00169	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—GSTM1—schizophrenia	4.4e-05	0.00167	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NTRK2—schizophrenia	4.34e-05	0.00165	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD3—schizophrenia	4.32e-05	0.00164	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—EP300—schizophrenia	4.28e-05	0.00162	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD4—schizophrenia	4.19e-05	0.00159	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PRODH—schizophrenia	4.17e-05	0.00158	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CNR1—schizophrenia	4e-05	0.00152	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD2—schizophrenia	3.91e-05	0.00148	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR7—schizophrenia	3.91e-05	0.00148	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	3.83e-05	0.00145	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRL—schizophrenia	3.69e-05	0.0014	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—S100B—schizophrenia	3.44e-05	0.0013	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MPC2—schizophrenia	3.4e-05	0.00129	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ERBB4—schizophrenia	3.29e-05	0.00125	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	3.17e-05	0.0012	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLCH2—schizophrenia	3.16e-05	0.0012	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PLA2G4A—schizophrenia	3.09e-05	0.00117	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TP53—schizophrenia	3.06e-05	0.00116	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NRG1—schizophrenia	3.03e-05	0.00115	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MEF2C—schizophrenia	3.01e-05	0.00114	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NDST3—schizophrenia	2.97e-05	0.00113	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—YWHAZ—schizophrenia	2.91e-05	0.0011	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ERBB3—schizophrenia	2.84e-05	0.00108	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACSL6—schizophrenia	2.82e-05	0.00107	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC27A5—schizophrenia	2.82e-05	0.00107	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	2.75e-05	0.00105	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR2A—schizophrenia	2.74e-05	0.00104	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DAO—schizophrenia	2.69e-05	0.00102	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—AKT1—schizophrenia	2.58e-05	0.00098	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PNP—schizophrenia	2.58e-05	0.000978	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOE—schizophrenia	2.54e-05	0.000965	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOA1—schizophrenia	2.51e-05	0.000954	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ESR1—schizophrenia	2.43e-05	0.000921	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NDUFV2—schizophrenia	2.4e-05	0.000909	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIP4K2A—schizophrenia	2.25e-05	0.000855	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GSK3B—schizophrenia	2.2e-05	0.000836	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP26B1—schizophrenia	2.04e-05	0.000773	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TPH1—schizophrenia	1.82e-05	0.000689	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GCLM—schizophrenia	1.82e-05	0.000689	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.71e-05	0.00065	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PRKD1—schizophrenia	1.71e-05	0.000648	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AKT1—schizophrenia	1.63e-05	0.00062	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AKT1—schizophrenia	1.48e-05	0.000563	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—EP300—schizophrenia	1.45e-05	0.00055	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GAPDH—schizophrenia	1.43e-05	0.000541	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CLOCK—schizophrenia	1.41e-05	0.000536	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.41e-05	0.000535	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.39e-05	0.000528	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TPH2—schizophrenia	1.38e-05	0.000522	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CACNB2—schizophrenia	1.38e-05	0.000522	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DPYD—schizophrenia	1.35e-05	0.000514	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CACNA1C—schizophrenia	1.26e-05	0.000478	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3C2A—schizophrenia	1.23e-05	0.000465	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SNAP25—schizophrenia	1.1e-05	0.000417	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP2D6—schizophrenia	1.1e-05	0.000417	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TP53—schizophrenia	1.04e-05	0.000394	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TH—schizophrenia	9.81e-06	0.000372	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AKT1—schizophrenia	8.76e-06	0.000332	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—COMT—schizophrenia	8.34e-06	0.000316	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GSTP1—schizophrenia	8.3e-06	0.000315	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MAOA—schizophrenia	8.28e-06	0.000314	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	8.03e-06	0.000305	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ABCB1—schizophrenia	7.86e-06	0.000298	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLA2G4A—schizophrenia	7.63e-06	0.000289	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GSTM1—schizophrenia	7.63e-06	0.000289	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MTHFR—schizophrenia	6.74e-06	0.000256	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOE—schizophrenia	6.27e-06	0.000238	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOA1—schizophrenia	6.2e-06	0.000235	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—EP300—schizophrenia	3.58e-06	0.000136	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—AKT1—schizophrenia	2.16e-06	8.2e-05	CbGpPWpGaD
